Phase I BP Interferon (IFN) Beta-001
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02515695 |
Recruitment Status :
Completed
First Posted : August 5, 2015
Last Update Posted : August 6, 2015
|
Sponsor:
Centre Hospitalier Universitaire Vaudois
Collaborator:
BioPartners GmbH
Information provided by (Responsible Party):
Prof. Jérôme Biollaz, MD, Centre Hospitalier Universitaire Vaudois
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 2005 |
Actual Study Completion Date : | July 2005 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):